Response to anti-programmed cell death protein-1 antibodies in men treated for platinum refractory germ cell cancer relapsed after high-dose chemotherapy and stem cell transplantation

Pembrolizumab versus Chemotherapy for PD-L1–Positive Non–Small-Cell Lung Cancer

Martin Reck, Delvys Rodríguez‐Abreu, Andrew Robinson et al. · New England Journal of Medicine · 2016 · 10.1K citations · Full text

Medicine, Oncology, Pharmacology +17

Nivolumab versus Everolimus in Advanced Renal-Cell Carcinoma

Robert J. Motzer, Bernard Escudier, Saby George et al. · New England Journal of Medicine · 2015 · 5.9K citations · Full text

Medicine, Oncology, Pharmacotherapy +17

High-Dose Chemotherapy and Stem-Cell Rescue for Metastatic Germ-Cell Tumors

Lawrence H. Einhorn, Stephen D. Williams, Amy R. Chamness et al. · New England Journal of Medicine · 2007 · 493 citations · Full text

Medicine, Cancer Biology, Oncology +16

Exploiting CTLA-4, PD-1 and PD-L1 to reactivate the host immune response against cancer

Sergio A. Quezada, Karl S. Peggs · British Journal of Cancer · 2013 · 199 citations · Full text

Medicine, Immunology, Oncology +17

Safety and Efficacy of Nivolumab in Patients With Metastatic Renal Cell Carcinoma Treated Beyond Progression

Saby George, Robert J. Motzer, Hans J. Hammers et al. · JAMA Oncology · 2016 · 178 citations · Full text

Medicine, Immunology, Oncology +17